Articles

FDA gets new report on Lilly diabetes drug

Drugmakers Eli Lilly and Co. and Amylin Pharmaceuticals Inc. said Monday that patients taking their potential once-weekly diabetes treatment, Bydureon, saw a significant improvement in cardiovascular risk factors.

Read More

IBM putting Watson to work in health insurance

IBM’s supercomputer system, best known for trouncing the world’s best “Jeopardy!” players on TV, is being tapped by one of the nation’s largest health insurers to help diagnose medical problems and authorize treatments.

Read More

Medical manufacturer plans Fishers expansion

Tridien Medical, a Coral Springs, Fla.-based manufacturer of therapeutic support surfaces, plans to expand its plant in Fishers, adding up to 40 new jobs by 2013, including 25 in the next year.

Read More

Q&A

Thad Johnson became CEO of Methodist Sports Medicine / The Orthopedic Specialists on June 15, the first time the 19-physician practice has had a non-physician executive.

Read More

Will ACOs really get off the ground?

The hype over accountable care organizations—something every major hospital in Indianapolis is moving to become—is increasingly being laced with skepticism as the economics behind the idea get more scrutiny.

Read More

Show-me state stings SynCare

Indianapolis-based SynCare LLC has been touting its growth in Missouri since it entered the market in 2009. But now SynCare’s excursions in the show-me state have turned into a nightmare.

Read More

Brokers ‘devastated’ by reform rule

The decision last year by the U.S. Department of Health and Human Services not to exclude health insurance brokers commissions from a provision in the 2010 health reform law has been “devastating to brokers,” broker advocate Janet Trautwein said during an August speech in Fishers, and there are signs that Congress will act to reverse the policy.

Read More

Gloomy outlook for medical device makers

The next four years could be rough for makers of medical devices and orthopedic implants, including Bloomington-based Cook Medical Inc. and Warsaw-based Zimmer Holding Inc. and Biomet Inc.—and not because of the 2010 health reform law.

Read More

Roche hopes to prosper from austerity

Executives at Roche Diagnostics expect the wave of austerity measures being taken by western governments—including the United States—to as much as double its sales of fluid- and DNA-based tests in the next three years.

Read More

Study spoils common wisdom on health spending

The Thomson Reuters study that showed Anderson as the highest-spending health care market in the nation also concluded that treatment and spending vary widely from one locale to another with no clear reason based on demographics or health outcomes.

Read More

Private firm with Medicaid deal gets state help

Officials with the Missouri Department of Health and Senior Services say they had to hire 13 temporary workers and shift as many as 20 state workers from their regular jobs after withering consumer complaints against SynCare LLC of Indiana.

Read More

Lawyer: Expect more hospital-doc lawsuits

With hospitals having scooped up hundreds of physicians in the past three years—putting nearly all of them under non-compete agreements—there are bound to be legal tussles when some of those physicians decide their new matches aren’t exactly made in heaven.

Read More

Savings power of HSAs appears to wane

As consumer-directed health plans become more prevalent, their power to save money for employers is waning, according to the latest survey by Indianapolis-based United Benefit Advisors.

Read More